NBIX vs. CART
NBIX (Neurocrine Biosciences, Inc.) and CART (Maplebear Inc. Common Stock) are both stocks. NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while CART operates in Internet Retail (Consumer Cyclical). Over the past year, NBIX returned 32.71% vs 0.83% for CART. At a 0.05 correlation, their price movements are largely independent.
Performance
NBIX vs. CART - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBIX achieves a 24.87% return, which is significantly higher than CART's 7.58% return.
NBIX
- 1D
- -1.91%
- 1M
- 8.85%
- 6M
- 30.43%
- YTD
- 24.87%
- 1Y
- 32.71%
- 3Y*
- 21.73%
- 5Y*
- 12.33%
- 10Y*
- 13.85%
CART
- 1D
- 0.23%
- 1M
- 15.49%
- 6M
- 17.54%
- YTD
- 7.58%
- 1Y
- 0.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NBIX vs. CART - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 24.87% | 3.90% | 3.60% | 17.67% |
CART Maplebear Inc. Common Stock | 7.58% | 8.59% | 76.48% | -44.12% |
Correlation
The correlation between NBIX and CART is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.11 |
Correlation (All Time) Calculated using the full available price history since Sep 19, 2023 | 0.05 |
The correlation between NBIX and CART shifts across timeframes, from -0.11 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NBIX:
$17.81B
CART:
$11.37B
NBIX:
$6.50
CART:
$1.81
NBIX:
27.23
CART:
26.67
NBIX:
0.54
CART:
0.11
NBIX:
5.87
CART:
3.35
NBIX:
5.37
CART:
5.59
NBIX:
$3.10B
CART:
$3.86B
NBIX:
$3.05B
CART:
$2.82B
NBIX:
$881.20M
CART:
$672.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBIX vs. CART — Risk / Return Rank
NBIX
CART
NBIX vs. CART - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Maplebear Inc. Common Stock (CART). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NBIX | CART | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.99 | ||
| Sortino ratioReturn per unit of downside risk | +1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.04 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.50 | -0.00 | +1.51 |
| Martin ratioReturn relative to average drawdown | 3.29 | -0.00 | +3.30 |
Loading charts...
Drawdowns
NBIX vs. CART - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than CART's maximum drawdown of -46.60%. Use the drawdown chart below to compare losses from any high point for NBIX and CART.
Loading charts...
Drawdown Indicators
| NBIX | CART | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.21% | -46.60% | -50.61% |
Max Drawdown (1Y)Largest decline over 1 year | -20.90% | -36.39% | +15.49% |
Max Drawdown (3Y)Largest decline over 3 years | -42.89% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -42.89% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -46.39% | — | — |
Current DrawdownCurrent decline from peak | -1.91% | -8.96% | +7.05% |
Average DrawdownAverage peak-to-trough decline | -43.74% | -20.78% | -22.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.52% | 20.77% | -11.25% |
Volatility
NBIX vs. CART - Volatility Comparison
The current volatility for Neurocrine Biosciences, Inc. (NBIX) is 8.08%, while Maplebear Inc. Common Stock (CART) has a volatility of 11.49%. This indicates that NBIX experiences smaller price fluctuations and is considered to be less risky than CART based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBIX | CART | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.08% | 11.49% | -3.41% |
Volatility (6M)Calculated over the trailing 6-month period | 23.42% | 32.16% | -8.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.73% | 42.93% | -11.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.83% | 46.97% | -14.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.03% | 46.97% | -7.94% |
Dividends
NBIX vs. CART - Dividend Comparison
Neither NBIX nor CART has paid dividends to shareholders.
Financials
NBIX vs. CART - Financials Comparison
This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Maplebear Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NBIX vs. CART - Profitability Comparison
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
CART - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Maplebear Inc. Common Stock reported a gross profit of 738.00M and revenue of 1.02B. Therefore, the gross margin over that period was 72.4%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
CART - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Maplebear Inc. Common Stock reported an operating income of 182.00M and revenue of 1.02B, resulting in an operating margin of 17.9%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
CART - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Maplebear Inc. Common Stock reported a net income of 144.00M and revenue of 1.02B, resulting in a net margin of 14.1%.
Frequently Asked Questions
NBIX and CART have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CART has higher volatility (11.49%) compared to NBIX (8.08%). In terms of maximum drawdown, NBIX dropped -97.21% vs CART's -46.60%.
NBIX currently has the higher Sharpe Ratio (0.99 vs -0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NBIX and CART
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer